Clinical Trial Update: Safety, Tolerability, and Effect of LY2405319 After Multiple Injections in Subjects With Type 2 Diabetes [Phase 1]

View source ↗

Summary

Phase 1 study assessing safety, tolerability, and preliminary effects of multiple injections of LY2405319 in adults with Type 2 diabetes mellitus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• LY2405319

Snippet

Sponsor: Eli Lilly and Company | Conditions: Type 2 Diabetes | Phase 1 | Status: COMPLETED